Related Experiment Video
Updated: Jan 20, 2026

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
Published on: June 27, 2025
Reversing the Tumor Target: Establishment of a Tumor Trap
Mathie Najberg1,2, Muhammad Haji Mansor1,3, Frank Boury1
1CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France.
Abstract:
Despite the tremendous progress made in the field of cancer therapy in recent years, certain solid tumors still cannot be successfully treated. Alongside classical treatments in the form of chemotherapy and/or radiotherapy, targeted treatments such as immunotherapy that cause fewer side effects emerge as new options in the clinics. However, these alternative treatments may not be useful for treating all types of cancers, especially for killing infiltrative and circulating tumor cells (CTCs). Recent advances pursue the trapping of these cancer cells within a confined area to facilitate their removal for therapeutic and diagnostic purposes. A good understanding of the mechanisms behind tumor cell migration may drive the design of traps that mimic natural tumor niches and guide the movement of the cancer cells. To bring this trapping idea into reality, strong efforts are being made to create structured materials that imitate myelinated fibers, blood vessels, or pre-metastatic niches and incorporate chemical cues such as chemoattractants or adhesive proteins. In this review, the different strategies used (or could be used) to trap tumor cells are described, and relevant examples of their performance are analyzed.
Insights
New strategies trap circulating tumor cells (CTCs) for cancer therapy. Understanding tumor cell migration aids in designing effective traps that mimic natural environments for improved cancer treatment and diagnostics.
Area of Science:
- Biomedical Engineering
- Oncology
- Materials Science
Background:
- Despite advances in cancer therapy, solid tumors and circulating tumor cells (CTCs) remain challenging to treat.
- Immunotherapy offers targeted treatment with fewer side effects but may not effectively eliminate infiltrative and CTCs.
Purpose of the Study:
- To review strategies for trapping cancer cells, particularly CTCs, for therapeutic and diagnostic applications.
- To explore the design of artificial tumor microenvironments that mimic natural niches to guide cancer cell migration.
Main Methods:
- Analysis of current and potential strategies for trapping tumor cells.
- Review of structured materials designed to imitate biological structures like myelinated fibers, blood vessels, or pre-metastatic niches.
- Examination of the incorporation of chemical cues (chemoattractants, adhesive proteins) in trapping materials.
Main Results:
- Various approaches are being developed to confine and remove cancer cells.
- Structured materials mimicking biological niches show promise in guiding cancer cell movement.
- Chemical cues enhance the efficacy of engineered tumor cell traps.
Conclusions:
- Trapping cancer cells, especially CTCs, represents a promising frontier in cancer therapy and diagnostics.
- Mimicking natural tumor microenvironments and utilizing chemical cues are key to developing effective trapping strategies.
- Further research into tumor cell migration mechanisms will drive innovation in designing advanced cancer cell traps.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Social Traps
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

